Patents Assigned to HALE BIOPHARMA VENTURES, LLC
  • Patent number: 9763876
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: September 19, 2017
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Patent number: 8895546
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: November 25, 2014
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Publication number: 20140170220
    Abstract: Multimodal particulate formulations of medicaments and methods for their use, e.g. by nasal or pulmonary administration for the treatment of various medical conditions, are provided.
    Type: Application
    Filed: September 9, 2013
    Publication date: June 19, 2014
    Applicant: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros
  • Patent number: 8530463
    Abstract: Multimodal particulate formulations of medicaments and methods for their use, e.g. by nasal or pulmonary administration for the treatment of various medical conditions, are provided.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: September 10, 2013
    Assignees: Hale Biopharma Ventures LLC, Aegis Therapeutics, LLC
    Inventors: Steve Cartt, David Medeiros, Edward T. Maggio
  • Publication number: 20090258865
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: March 27, 2009
    Publication date: October 15, 2009
    Applicant: HALE BIOPHARMA VENTURES, LLC
    Inventors: Steve Cartt, David Medeiros, Gary Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale